UAE Banking Heavyweight Joins NeOnc as Global Brain-Cancer Drug Development Advances

Go back to UAE Banking Heavyweight Joins NeOnc as Global Brain-Cancer Drug Development Advances
(NASDAQ: NTHI) Delayed: 2.70 -0.05 (1.82%)
Previous Close $2.75    52 Week High $ 
Open $2.80    52 Week Low $ 
Day High $2.84    P/E N/A 
Day Low $2.69    EPS $ 
Volume 104,422